Targeted Oncology presents Investigator Perspectives, a video series featuring key opinion leaders discussing how to approach and manage patients with different tumor types.
Practice Updates in Adjuvant Immune Checkpoint Inhibition for Bladder Cancer
Read More
Emerging Treatment Updates: Antibody Drug Conjugates in Relapsed/Refractory Follicular Lymphoma
Anemia Management in LR-MDS: Treatment Insights From ASH 2024
Emerging Updates in Front-Line Immunotherapy for Unresectable Hepatocellular Carcinoma (uHCC)
SABCS 2024: Updates From Clinical Trials of Elacestrant for ER+/HER2– Metastatic Breast Cancer From SABCS 2024
Updates in EGFR-Mutant Advanced NSCLC – First- and Second-Line Treatment
Beyond the Basics – Lower-Risk Myelodysplastic Syndromes
INVESTIGATOR PERSPECTIVES Application of a Tissue-Free Epigenomic Assay to Improve MRD Detection in Previously Treated CRC
Evolving Landscape of First-Line Therapies in Metastatic RCC: Cabozantinib-Based Approaches
Evolving Role of BTKis in CLL/SLL: Highlights from EHA 2024
Recent Advances for Treating Anemia in Lower-Risk Myelodysplastic Syndromes
Recent Updates in the Treatment Landscape for Advanced Non-Clear Cell Renal Carcinoma
Recent Advances for CAR T- Cell Therapy in R/R Multiple Myeloma
The Evolving Landscape of Non-Clear Cell Renal Cell Carcinoma
Optimizing Therapy for Lower-Risk MDS
PERSEUS Primary Analysis Findings in Patients With Newly Diagnosed Multiple Myeloma Who Are Eligible for Stem Cell Transplantation
Advancing BTKis in R/R CLL/SLL: Highlights from ASH 2023
Expert Insights into Recent Updates for the Management of Lower-Risk MDS
Emergent Advances and Subgroup Data in ER+, HER2- Metastatic Breast Cancer from SABCS 2023
The Evolving Treatment Landscape in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer
Managing Myelofibrosis Patients With Anemia
Dialogue in Diagnostics: Optimizing ESR1m Testing in ER+/HER2- Metastatic Breast Cancer
Endometrial Carcinoma Treatment Advances
Renal Cell Carcinoma Treatment Updates from ASCO 2023 and KCRS 2023
Transforming Outcomes: Optimizing Survival, Quality of Life & Treatment Strategies in Advanced RCC
Advances in the First-Line Treatment of Anemia Associated With Lower-Risk Myelodysplastic Syndromes (LR-MDS): Phase 3 COMMANDS Trial Data
Developing Strategies for Myelofibrosis Treatment
Advances in Myelofibrosis Treatment
Understanding Radioactive Iodine-Refractory Differentiated Thyroid Cancer (RAI-R-DTC)
Metastatic Renal Cell Carcinoma: Updates to CheckMate 9ER and COSMIC-313 Trial Data